RALPH VINCENT FONTEJON: Open Payments
NPI 1477101624 · PORTER RANCH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$137 in 5 payments from 4 companies in 2025. Trend: 2023 $67 · 2024 $42 · 2025 $137
Food & beverage: $137
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $64 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
Products named: Ozempic, M-M-R II, Wegovy, BEXSERO, GVOKE HYPOPEN.
Industry payments across CA — which companies pay providers there.
